These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 10549691

  • 1. Venlafaxine versus fluoxetine.
    Paton C.
    J Clin Psychiatry; 1999 Oct; 60(10):708. PubMed ID: 10549691
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Serotonin reuptake inhibitors in Raynaud's phenomenon.
    Jaffe IA.
    Lancet; 1995 May 27; 345(8961):1378. PubMed ID: 7752794
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.
    Silverstone PH, Salinas E.
    J Clin Psychiatry; 2001 Jul 27; 62(7):523-9. PubMed ID: 11488362
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.
    Brent DA.
    Depress Anxiety; 2009 Jul 27; 26(10):871-4. PubMed ID: 19798756
    [No Abstract] [Full Text] [Related]

  • 12. Once-daily venlafaxine extended release (XR) vs. fluoxetine for the treatment of depression.
    Judge R.
    J Affect Disord; 2001 Sep 27; 66(1):95-8. PubMed ID: 11592259
    [No Abstract] [Full Text] [Related]

  • 13. Problems with ensuring a double blind.
    Kumar S, Oakley-Browne M.
    J Clin Psychiatry; 2001 Apr 27; 62(4):295-6. PubMed ID: 11379846
    [No Abstract] [Full Text] [Related]

  • 14. Combination treatment with venlafaxine and bupropion.
    Kirsch MA, Louie AK.
    Am J Psychiatry; 1999 Mar 27; 156(3):494. PubMed ID: 10080572
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Time to rehospitalization in patients with major depressive disorder taking venlafaxine or fluoxetine.
    Lin CH, Lin KS, Lin CY, Chen MC, Lane HY.
    J Clin Psychiatry; 2008 Jan 27; 69(1):54-9. PubMed ID: 18312038
    [Abstract] [Full Text] [Related]

  • 18. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.
    Thase ME, Entsuah AR, Rudolph RL.
    Br J Psychiatry; 2001 Mar 27; 178():234-41. PubMed ID: 11230034
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Venlafaxine-induced hair loss.
    Pitchot W, Ansseau M.
    Am J Psychiatry; 2001 Jul 27; 158(7):1159-60. PubMed ID: 11431245
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.